Clinical Trial Update: Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on photodynamic therapy with LUZ11 for advanced head and neck cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• LUZ11

Snippet

Sponsor: Luzitin SA | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: UNKNOWN